A detailed history of Savant Capital, LLC transactions in Grifols Sa stock. As of the latest transaction made, Savant Capital, LLC holds 14,011 shares of GRFS stock, worth $122,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,011
Previous 12,076 16.02%
Holding current value
$122,035
Previous $109,000 27.52%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$8.87 - $10.85 $17,163 - $20,994
1,935 Added 16.02%
14,011 $139,000
Q2 2025

Aug 06, 2025

BUY
$6.49 - $9.09 $1,051 - $1,472
162 Added 1.36%
12,076 $109,000
Q1 2025

May 08, 2025

BUY
$6.62 - $8.71 $78,870 - $103,770
11,914 New
11,914 $84,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.91B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.